A promising new pancreatic cancer treatment pill has shown remarkable results, helping advanced patients live significantly ...

Acute pancreatitis is a common and costly gastrointestinal condition with significant risk of complications. The 2024 ...

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...

(Corrects paragraph 5 to say "doubled" not "reduced") By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's ...

For decades, scientists have been working to find solutions for pancreatic cancer, which is often diagnosed late and has few ...

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

While the drug is not a cure, researchers say it could meaningfully improve both the length and quality of life for patients ...

The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.

By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients ...

Revolution Medicines Inc.’s experimental pancreatic cancer drug daraxonrasib delayed painful symptoms for months, in addition ...

A DAD who threw up a litre of blood while sitting by the pool on holiday has told how medics blamed it on sunstroke. Peter ...